Showing 26–28 of 28 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Nataliia Lytvynenko, Maryna Pogrebna, Yuliia Senko, Yurii Gamazin, Iana Terleeva
BPaL implementation started in Ukraine in November 2020, with the National Institute for TB and Lung Diseases (TB Institute), under TB Reach “Pilot Study to Evaluate the Effectiveness and Safety of the BPaL Treatment Regimen in Ukraine” project implemented by Organization for App…
O.B. Pikas, M.A. Semeniuk
…0—45 %. The inclusion of second-line drugs in the treatment regimen of patients with isoniazid-resistant tuberculosis increases the effectiveness of treatment by 11.8 %. The overall effectiveness of treatment of patients with multidrug-resistant tuberculosis (MDR-TB) in the wor…
Preeti Preeti, Ameeta Joshi, Madhuparna Dev
…ezolid, and 11.1% were resistant. Linezolid sensitivity for MDR-TB patients was 88.72% of the cases being sensitive, and 11.28% resistant. Linezolid sensitivity in pre-extensively drug-resistant tuberculosis was 88.27% and 11.73% were resistant. Among 1031 samples, 50 samples tak…